用临床试验中的真实数据对外部控制臂进行定量偏差分析:临床研究人员的一本入门书
Kristian Thorlund1, Stephen Duffield2, Sanjay Popat3
1Dept. Health Research Methods, Evidence, & Impact, McMaster University, ON, Canada.
Journal of comparative effectiveness research
|January 11, 2024
概括
定量偏差分析 (QBA) 可以在罕见癌症试验中验证外部控制臂的真实数据. 这种方法确保了治疗疗效估计的可靠性,尽管缺少数据和潜在的混因素.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 现实世界的证据.
背景情况:
- 对罕见癌症的药物开发面临传统随机对照试验的挑战.
- 使用真实世界数据 (RWD) 的外部控制臂至关重要,但具有固有的局限性,如缺少数据和混.
- 定量偏差分析 (QBA) 提供了模拟和评估RWD中的系统错误的方法.
研究的目的:
- 探索QBA在评估来自外部控制臂的比较疗效估计中的应用.
- 展示QBA如何在处理数据限制时评估发现的稳定性.
主要方法:
- 概述各种QBA方法,从简单的方程到复杂的模型.
- 应用QBA使用一个案例研究比较pralsetinib (单臂试验) 与 pembrolizumab (RWD) 在RET融合阳性高级非小细胞肺癌 (aNSCLC) 中.
- 使用临界点分析和E值来评估对缺失数据和潜在未测量的混的稳定性.
主要成果:
- 应用了QBA来评估单臂试验和外部RWD控制臂之间的比较疗效估计的有效性.
- 分析表明,尽管关于ECOG绩效状况的重要数据缺失,但调查结果的可靠性仍然很强.
- 临界点分析和E值证实,结果不会因潜在的混而有意义地改变.
结论:
- 在使用RWD的外部控制臂时,QBA是验证比较疗效估计的宝贵工具.
- 该方法提高了在罕见的瘤群体中试验结果的可靠性,传统试验难以实现.
- QBA提供了一个框架,可以系统地解决和量化现实世界数据中固有的偏差.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
129
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
129
Bias in Epidemiological Studies
274
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
274
Bias
4.2K
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
4.2K
Controls in Experiments
7.7K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
7.7K
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Hazard Ratio
128
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
128


